Haemonetics Corporation (HAE) — Capital Reinvestment Ratio

Latest as of March 2026: 0.25x

Haemonetics Corporation (HAE) has a Capital Reinvestment Ratio of 0.25x as of March 2026, meaning it reinvests 0% of its operating cash flow ($70.94 Million) in capital expenditures ($17.66 Million). See Haemonetics Corporation balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.25x
Capex / Operating Cash Flow

Operating Cash Flow

$70.94 Million
USD

Capital Expenditures

$17.66 Million
USD

Data as of

Mar 2026
Most recent filing

Haemonetics Corporation Capital Reinvestment Ratio (1992–2026)

This chart tracks Haemonetics Corporation's Capital Reinvestment Ratio across 35 annual periods. Check how aggressively does Haemonetics Corporation reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Haemonetics Corporation (1992–2026)

Year-by-year Capital Reinvestment Ratio for Haemonetics Corporation from 1992 to 2026. For live market cap and broader valuation context, see how much is Haemonetics Corporation worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2026 0.11x $293.22 Million $32.78 Million ▼ -48.3%
2025 0.22x $181.72 Million $39.28 Million ▼ -40.7%
2024 0.36x $181.75 Million $66.30 Million ▼ -9.6%
2023 0.40x $273.06 Million $110.19 Million ▼ -28.0%
2022 0.56x $172.26 Million $96.51 Million ▲ +64.6%
2021 0.34x $108.81 Million $37.04 Million ▲ +10.5%
2020 0.31x $158.22 Million $48.76 Million ▼ -58.7%
2019 0.75x $159.28 Million $118.96 Million ▲ +120.0%
2018 0.34x $220.35 Million $74.80 Million ▼ -28.8%
2017 0.48x $159.74 Million $76.14 Million ▼ -43.3%
2016 0.84x $121.86 Million $102.41 Million ▼ -12.6%
2015 0.96x $127.18 Million $122.22 Million ▲ +82.1%
2014 0.53x $139.52 Million $73.65 Million ▼ -27.8%
2013 0.73x $85.07 Million $62.19 Million ▲ +58.5%
2012 0.46x $115.32 Million $53.20 Million ▲ +22.0%
2011 0.38x $123.45 Million $46.67 Million ▼ -12.3%
2010 0.43x $130.67 Million $56.30 Million ▼ -11.1%
2009 0.48x $116.36 Million $56.38 Million ▼ -34.9%
2008 0.74x $77.67 Million $57.79 Million ▲ +50.0%
2007 0.50x $83.56 Million $41.46 Million ▲ +15.5%
2006 0.43x $85.62 Million $36.77 Million ▲ +74.5%
2005 0.25x $71.21 Million $17.53 Million ▲ +32.5%
2004 0.19x $74.61 Million $13.86 Million ▼ -40.1%
2003 0.31x $43.67 Million $13.54 Million ▼ -53.7%
2002 0.67x $32.24 Million $21.60 Million ▲ +33.9%
2001 0.50x $61.01 Million $30.54 Million ▲ +14.8%
2000 0.44x $53.47 Million $23.32 Million ▼ -34.7%
1999 0.67x $33.70 Million $22.50 Million ▼ -33.2%
1998 1.00x $20.40 Million $20.40 Million ▼ -16.6%
1997 1.20x $26.70 Million $32.00 Million ▲ +233.4%
1996 0.36x $54.80 Million $19.70 Million ▼ -77.5%
1995 1.60x $15.60 Million $24.90 Million ▲ +88.2%
1994 0.85x $27.00 Million $22.90 Million ▲ +73.0%
1993 0.49x $35.90 Million $17.60 Million ▼ -19.2%
1992 0.61x $18.80 Million $11.40 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow